Exposure limits · European Union
European Union exposure limits: Binding occupational exposure limit values (BOELV): 2004/37/EC Annex III, 98/24/EC Annex I, 2009/148/EC
All member states must set national limits at or below these values. 80 limit values, version 2026-10-30. Check the substances in section 3 and the limits in section 8 of your safety data sheets against this list.
- Legal status
- indicative (IOELV) and binding (BOELV)
- Version date
- 2026-10-30
- Values
- 80
- Guide
- European Union rules
Limit values
80 rows
| Substance | CAS | EC | 8 h ppm | 8 h mg/m³ | 15 min ppm | 15 min mg/m³ | f/cm³ | Fraction | Notes | Valid |
|---|---|---|---|---|---|---|---|---|---|---|
| Hardwood dusts | 2 | inhalable | (8) | from 2023-01-18 | ||||||
| Hardwood dusts | 3 | inhalable | (8) | until 2023-01-17 | ||||||
| Chromium (VI) compounds which are carcinogens within the meaning of point (i) of Article 2(a) (as chromium) | 0,005 | from 2025-01-18 | ||||||||
| Chromium (VI) compounds which are carcinogens within the meaning of point (i) of Article 2(a) (as chromium) | 0,010 | until 2025-01-17 | ||||||||
| Chromium (VI) compounds which are carcinogens within the meaning of point (i) of Article 2(a) (as chromium) | 0,025 | until 2025-01-17 | ||||||||
| Refractory ceramic fibres which are carcinogens within the meaning of point (i) of Article 2(a) | 0,3 | |||||||||
| Respirable crystalline silica dust | 0,1 | respirable | (9) | |||||||
| Benzene | 71-43-2 | 200-753-7 | 0,2 | 0,66 | Skin (15) | from 2026-04-06 | ||||
| Benzene | 71-43-2 | 200-753-7 | 1 | 3,25 | Skin (15) | until 2024-04-05 | ||||
| Benzene | 71-43-2 | 200-753-7 | 0,5 | 1,65 | Skin (15) | from 2024-04-05 until 2026-04-05 | ||||
| Vinyl chloride monomer | 75-01-4 | 200-831-0 | 1 | 2,6 | ||||||
| Ethylene oxide | 75-21-8 | 200-849-9 | 1 | 1,8 | skin (10) | |||||
| 1,2-Epoxypropane | 75-56-9 | 200-879-2 | 1 | 2,4 | ||||||
| Trichloroethylene | 79-01-6 | 201-167-4 | 10 | 54,7 | 30 | 164,1 | skin (10) | |||
| Acrylamide | 79-06-1 | 201-173-7 | 0,1 | skin (10) | ||||||
| 2-Nitropropane | 79-46-9 | 201-209-1 | 5 | 18 | ||||||
| o-Toluidine | 95-53-4 | 202-429-0 | 0,1 | 0,5 | skin (10) | |||||
| 4,4′-Methylenedianiline | 101-77-9 | 202-974-4 | 0,08 | skin (10) | ||||||
| Epichlorohydrine | 106-89-8 | 203-439-8 | 1,9 | skin (10) | ||||||
| Ethylene dibromide | 106-93-4 | 203-444-5 | 0,1 | 0,8 | skin (10) | |||||
| 1,3-Butadiene | 106-99-0 | 203-450-8 | 1 | 2,2 | ||||||
| Ethylene dichloride | 107-06-2 | 203-458-1 | 2 | 8,2 | skin (10) | |||||
| Hydrazine | 302-01-2 | 206-114-9 | 0,01 | 0,013 | skin (10) | |||||
| Bromoethylene | 593-60-2 | 209-800-6 | 1 | 4,4 | ||||||
| Diesel engine exhaust emissions | 0,05 | measured as elemental carbon | (*) | from 2023-02-21 | ||||||
| Polycyclic aromatic hydrocarbons mixtures, particularly those containing benzo[a]pyrene, which are carcinogens within the meaning of this Directive | skin (10) | until 2026-11-18 | ||||||||
| Mineral oils that have been used before in internal combustion engines to lubricate and cool the moving parts within the engine | skin (10) | |||||||||
| Cadmium and its inorganic compounds | 0,001 | inhalable | (11) | from 2027-07-12 | ||||||
| Cadmium and its inorganic compounds | 0,004 | inhalable (respirable in Member States with a biomonitoring system, see footnote 12) | (12) | until 2027-07-11 | ||||||
| Beryllium and inorganic beryllium compounds | 0,0002 | inhalable | (11), dermal and respiratory sensitisation (13) | from 2026-07-12 | ||||||
| Beryllium and inorganic beryllium compounds | 0,0006 | inhalable | (11), dermal and respiratory sensitisation (13) | until 2026-07-11 | ||||||
| Arsenic acid and its salts, as well as inorganic arsenic compounds | 0,01 | inhalable | (11) | |||||||
| Formaldehyde | 50-00-0 | 200-001-8 | 0,3 | 0,37 | 0,6 | 0,74 | dermal sensitisation (14) | |||
| Formaldehyde | 50-00-0 | 200-001-8 | 0,5 | 0,62 | dermal sensitisation (14) | until 2024-07-11 | ||||
| 4,4′-Methylene-bis (2-chloroaniline) | 101-14-4 | 202-918-9 | 0,01 | skin (10) | ||||||
| Acrylonitrile | 107-13-1 | 203-466-5 | 0,45 | 1 | 1,8 | 4 | Skin (10), Dermal sensitisation (14) | from 2026-04-05 | ||
| Nickel compounds | 0,01 | respirable, measured as nickel | (15), Dermal and respiratory sensitisation (13) | from 2025-01-18 | ||||||
| Nickel compounds | 0,05 | inhalable, measured as nickel | (16), Dermal and respiratory sensitisation (13) | from 2025-01-18 | ||||||
| Nickel compounds | 0,1 | inhalable, measured as nickel | (16), Dermal and respiratory sensitisation (13) | until 2025-01-17 | ||||||
| Lead and its inorganic compounds | 0,03 | inhalable | (11), Non-threshold reprotoxic substance | |||||||
| N,N-Dimethylacetamide | 127-19-5 | 204-826-4 | 10 | 36 | 20 | 72 | Skin (10) | |||
| Nitrobenzene | 98-95-3 | 202-716-0 | 0,2 | 1 | Skin (10) | |||||
| N,N Dimethylformamide | 68-12-2 | 200-679-5 | 5 | 15 | 10 | 30 | Skin (10) | |||
| 2-Methoxyethanol | 109-86-4 | 203-713-7 | 1 | Skin (10) | ||||||
| 2-Methyoxyethyl acetate | 110-49-6 | 203-772-9 | 1 | Skin (10) | ||||||
| 2-Ethoxy ethanol | 110-80-5 | 203-804-1 | 2 | 8 | Skin (10) | |||||
| 2-Ethoxyethyl acetate | 111-15-9 | 203-839-2 | 2 | 11 | Skin (10) | |||||
| 1-Methyl-2-pyrrolidone | 872-50-4 | 212-828-1 | 10 | 40 | 20 | 80 | Skin (10) | |||
| Mercury and divalent inorganic mercury compounds including mercuric oxide and mercuric chloride (measured as mercury) | 0,02 | until 2026-11-18 | ||||||||
| Bisphenol A; 4,4′-Isopropylidenediphenol | 80-05-7 | 201-245-8 | 2 | inhalable | (11) | |||||
| Carbon monoxide | 630-08-0 | 211-128-3 | 20 | 23 | 100 | 117 | ||||
| Polycyclic aromatic hydrocarbons mixtures, particularly those containing benzo[a]pyrene, which are carcinogens, mutagens or reprotoxic substances as defined in this Directive | 0,00007 | measured as benzo[a]pyrene | (17), Skin (10) | from 2026-11-19 | ||||||
| Polycyclic aromatic hydrocarbons mixtures, particularly those containing benzo[a]pyrene, which are carcinogens, mutagens or reprotoxic substances as defined in this Directive | 0,00014 | measured as benzo[a]pyrene | (17), Skin (10) | from 2026-11-19 until 2033-11-20 | ||||||
| Mercury and divalent inorganic mercury compounds that fall within the scope of this Directive (measured as mercury) | 0,02 | from 2026-11-19 | ||||||||
| Cobalt and inorganic cobalt compounds | 0,01 | inhalable, measured as cobalt | (18), dermal and respiratory sensitisation (13) | from 2032-11-21 | ||||||
| Cobalt and inorganic cobalt compounds | 0,0025 | respirable, measured as cobalt | (19), dermal and respiratory sensitisation (13) | from 2032-11-21 | ||||||
| Cobalt and inorganic cobalt compounds | 0,02 | inhalable, measured as cobalt | (18), dermal and respiratory sensitisation (13) | from 2026-11-19 until 2032-11-20 | ||||||
| Cobalt and inorganic cobalt compounds | 0,0042 | respirable, measured as cobalt | (19), dermal and respiratory sensitisation (13) | from 2026-11-19 until 2032-11-20 | ||||||
| Isoprene | 78-79-5 | 201-143-3 | 3 | 8,5 | from 2026-11-19 | |||||
| 1,4-dioxane | 123-91-1 | 204-661-8 | 2 | 7,3 | 20 | 73 | Skin (10) | from 2026-11-19 | ||
| Diisocyanates (measured as NCO) | 6 μg/m3 | 12 μg/m3 | measured as NCO | Skin (8), Dermal and respiratory sensitisation (9) | from 2029-01-01 | |||||
| Diisocyanates (measured as NCO) | 10 μg NCO/m3 | 20 μg NCO/m3 | measured as NCO | Skin (8), Dermal and respiratory sensitisation (9) | until 2028-12-31 | |||||
| asbestos, actinolite | 77536-66-4 | 0,01 | until 2029-12-20 | |||||||
| asbestos, actinolite | 77536-66-4 | 0,01 | from 2029-12-21 | |||||||
| asbestos, actinolite | 77536-66-4 | 0,002 | from 2029-12-21 | |||||||
| asbestos, amosite (grunerite) | 12172-73-5 | 0,01 | until 2029-12-20 | |||||||
| asbestos, amosite (grunerite) | 12172-73-5 | 0,01 | from 2029-12-21 | |||||||
| asbestos, amosite (grunerite) | 12172-73-5 | 0,002 | from 2029-12-21 | |||||||
| asbestos, anthophyllite | 77536-67-5 | 0,01 | until 2029-12-20 | |||||||
| asbestos, anthophyllite | 77536-67-5 | 0,01 | from 2029-12-21 | |||||||
| asbestos, anthophyllite | 77536-67-5 | 0,002 | from 2029-12-21 | |||||||
| asbestos, chrysotile | 12001-29-5 | 0,01 | until 2029-12-20 | |||||||
| asbestos, chrysotile | 12001-29-5 | 0,01 | from 2029-12-21 | |||||||
| asbestos, chrysotile | 12001-29-5 | 0,002 | from 2029-12-21 | |||||||
| asbestos, crocidolite | 12001-28-4 | 0,01 | until 2029-12-20 | |||||||
| asbestos, crocidolite | 12001-28-4 | 0,01 | from 2029-12-21 | |||||||
| asbestos, crocidolite | 12001-28-4 | 0,002 | from 2029-12-21 | |||||||
| asbestos, tremolite | 77536-68-6 | 0,01 | until 2029-12-20 | |||||||
| asbestos, tremolite | 77536-68-6 | 0,01 | from 2029-12-21 | |||||||
| asbestos, tremolite | 77536-68-6 | 0,002 | from 2029-12-21 |
Notes legend
As written in the official source.
- (*)
- Measured as elemental carbon.
- (8)
- Inhalable fraction: if hardwood dusts are mixed with other wood dusts, the limit value shall apply to all wood dusts present in that mixture.
- (9)
- Respirable fraction.
- (10)
- Substantial contribution to the total body burden via dermal exposure possible.
- (11)
- Inhalable fraction.
- (12)
- Inhalable fraction. Respirable fraction in those Member States that implement, on the date of the entry into force of this Directive, a biomonitoring system with a biological limit value not exceeding 0,002 mg Cd/g creatinine in urine.
- (13)
- The substance can cause sensitisation of the skin and of the respiratory tract.
- (14)
- The substance can cause sensitisation of the skin.
- (15)
- Respirable fraction, measured as nickel.
- (16)
- Inhalable fraction, measured as nickel.
- (17)
- Measured as benzo[a]pyrene.
- (18)
- Inhalable fraction, measured as cobalt.
- (19)
- Respirable fraction, measured as cobalt.
- Skin
- substantial contribution to the total body burden via dermal exposure possible. The consolidated text prints Skin (15), but footnote (15) of Annex III reads Respirable fraction, measured as nickel; the amending Directive (EU) 2022/431 prints Skin (8), which in its own legend is the dermal footnote, so (15) is a numbering error in the consolidated text
Official source
- reachlex.eu/en/carcinogens-mutagens-reprotoxic/annex-iii
- eur-lex.europa.eu/eli/dir/2026/2450/oj
- reachlex.eu/en/chemical-agents/annex-i
- eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:02009L0148-20231220
Values are copied exactly as published, without conversion or rounding. Not legal advice; always check the official text.